IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v45y2022i1d10.1007_s40264-021-01137-0.html
   My bibliography  Save this article

The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions

Author

Listed:
  • Gianmario Candore

    (European Medicines Agency)

  • Sebastian Monzon

    (European Medicines Agency)

  • Jim Slattery

    (European Medicines Agency)

  • Loris Piccolo

    (European Medicines Agency)

  • Rodrigo Postigo

    (European Medicines Agency)

  • Xavier Xurz

    (European Medicines Agency)

  • Sabine Strauss

    (CBG-MEB
    EMA Pharmacovigilance Risk Assessment Committee)

  • Peter Arlett

    (European Medicines Agency)

Abstract

Introduction and Objective European Union legislation has mandated the submission of European Economic Area non-serious reports to the EudraVigilance database since November 2017. As spontaneous reports of suspected adverse reactions to medicines represent a key source of safety signals, the European Medicines Agency has undertaken this work to assess the effects of this requirement on the characteristics of the reports submitted to EudraVigilance and on the detection of adverse drug reactions through routine analyses of the database. Methods Changes in the numbers of serious and non-serious reports transmitted to EudraVigilance were examined over the period during which the legislation was implemented. The numbers and nature of potential safety signals emerging from established statistical algorithms used at the European Medicines Agency applied either to only the serious reports or to all reports in EudraVigilance were compared. Results Up to November 2017, less than 25% of European Economic Area reports in EudraVigilance were classified as non-serious, since than this figure was slightly above 60%. This change accompanied an increase in the total number of reports received. Addition of non-serious reports to the signal detection process resulted in a small overall increase in signals of disproportionate reporting with some new signals of disproportionate reporting appearing and some existing signals of disproportionate reporting disappearing; the sensitivity of the signal detection system was slightly increased and the proportion of signals of disproportionate reporting that corresponded to known adverse drug reactions (a measure of efficiency) was unchanged. Conclusions The change in legislation has led to a small increase in sensitivity, without affecting the efficiency of the routine statistical measures used. The number of non-serious reports as a proportion of reports in EudraVigilance is likely to increase over time and further monitoring of the impact on signal detection is required. Further work is also required on the qualitative impact of non-serious reports on the nature of signals detected and on their evaluation.

Suggested Citation

  • Gianmario Candore & Sebastian Monzon & Jim Slattery & Loris Piccolo & Rodrigo Postigo & Xavier Xurz & Sabine Strauss & Peter Arlett, 2022. "The Impact of Mandatory Reporting of Non-Serious Safety Reports to EudraVigilance on the Detection of Adverse Reactions," Drug Safety, Springer, vol. 45(1), pages 83-95, January.
  • Handle: RePEc:spr:drugsa:v:45:y:2022:i:1:d:10.1007_s40264-021-01137-0
    DOI: 10.1007/s40264-021-01137-0
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-021-01137-0
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1007/s40264-021-01137-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Suzie Seabroke & Gianmario Candore & Kristina Juhlin & Naashika Quarcoo & Antoni Wisniewski & Ramin Arani & Jeffery Painter & Philip Tregunno & G. Niklas Norén & Jim Slattery, 2016. "Performance of Stratified and Subgrouped Disproportionality Analyses in Spontaneous Databases," Drug Safety, Springer, vol. 39(4), pages 355-364, April.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Jeremy D. Jokinen & Rosalind J. Walley & Michael W. Colopy & Thomas S. Hilzinger & Peter Verdru, 2019. "Pooling Different Safety Data Sources: Impact of Combining Solicited and Spontaneous Reports on Signal Detection In Pharmacovigilance," Drug Safety, Springer, vol. 42(10), pages 1191-1198, October.
    2. Carine Cohen & Annick Houdeau & Alena Khromava, 2018. "Comment on “Central Demyelinating Diseases After Vaccination Against Hepatitis B Virus: A Disproportionality Analysis Within the VAERS Database”," Drug Safety, Springer, vol. 41(12), pages 1425-1427, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:45:y:2022:i:1:d:10.1007_s40264-021-01137-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.